$NEO NEOGENOMICS INC Insider Trading Week 22/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEOGENOMICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEOGENOMICS INC in week 22/2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 30 2017 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | A | 0.00 | 8,667 | 0 | 8,667 | |
May 30 2017 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | A | 7.27 | 10,000 | 72,700 | 10,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | C | 0.00 | 5,072 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | C | 0.00 | 2,150 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Buy | M | 0.00 | 7,222 | 0 | 272,016 | 264.8 K to 272 K (+2.73 %) |
May 30 2017 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 0.00 | 8,667 | 0 | 8,667 | |
May 30 2017 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 7.27 | 10,000 | 72,700 | 10,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | C | 0.00 | 5,072 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | C | 0.00 | 2,150 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Buy | M | 0.00 | 7,222 | 0 | 21,782 | 14.6 K to 21.8 K (+49.60 %) |
May 30 2017 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | A | 0.00 | 8,667 | 0 | 8,667 | |
May 30 2017 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | A | 7.27 | 10,000 | 72,700 | 10,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | C | 0.00 | 5,072 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | C | 0.00 | 2,150 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Buy | M | 0.00 | 7,222 | 0 | 17,202 | 10 K to 17.2 K (+72.36 %) |
May 30 2017 | NEO | NEOGENOMICS INC | Robison William J | Director | Option Exercise | A | 0.00 | 8,667 | 0 | 8,667 | |
May 30 2017 | NEO | NEOGENOMICS INC | Robison William J | Director | Option Exercise | A | 7.27 | 10,000 | 72,700 | 10,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | Robison William J | Director | Option Exercise | C | 0.00 | 5,072 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | Robison William J | Director | Option Exercise | C | 0.00 | 2,150 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | Robison William J | Director | Buy | M | 0.00 | 7,222 | 0 | 183,348 | 176.1 K to 183.3 K (+4.10 %) |
May 30 2017 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive VP of Fin ... | Option Exercise | A | 0.00 | 8,667 | 0 | 8,667 | |
May 30 2017 | NEO | NEOGENOMICS INC | JONES STEVEN C | Executive VP of Fin ... | Option Exercise | A | 7.27 | 10,000 | 72,700 | 10,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | A | 0.00 | 8,667 | 0 | 8,667 | |
May 30 2017 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | A | 7.27 | 10,000 | 72,700 | 10,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | C | 0.00 | 5,072 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | C | 0.00 | 2,150 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Buy | M | 0.00 | 7,222 | 0 | 128,309 | 121.1 K to 128.3 K (+5.96 %) |
May 30 2017 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 0.00 | 8,667 | 0 | 8,667 | |
May 30 2017 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 7.27 | 10,000 | 72,700 | 10,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | C | 0.00 | 5,072 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | C | 0.00 | 2,150 | 0 | 0 | |
May 30 2017 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Buy | M | 0.00 | 7,222 | 0 | 18,782 | 11.6 K to 18.8 K (+62.47 %) |
May 30 2017 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | A | 0.00 | 197,042 | 0 | 197,042 | |
May 30 2017 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | Chief Financial Off ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Sell | S | 7.50 | 3,334 | 25,005 | 10,049 | 13.4 K to 10 K (-24.91 %) |
May 30 2017 | NEO | NEOGENOMICS INC | ALBITAR MAHER | Chief Medical Offic ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 |